山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (2): 118-120.doi: 10.6040/j.issn.1671-7554.0.2021.1329
亓梦雨,周敏然,孙洺山,李世洁,陈春燕
中图分类号:
| [1] Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016, 127(20): 2391-2405. [2] Vannucchi AM, Masala G, Antonioli E, et al. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms[J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(7): 2068-2073. [3] Marchetti M, Carobbio A, Capitoni E, et al. Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: a systematic review[J]. Am J Hematol, 2018, 93(5): 698-703. [4] Holst JM, Plesner TL, Pedersen MB, et al. Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort[J]. Haematologica, 2020, 105(10): 2432-2439. [5] Cheon HJ, Dziewulska KH, Moosic KB, et al. Advances in the diagnosis and treatment of large granular lymphocytic leukemia[J]. Curr Hematol Malig Rep, 2020, 15(2): 103-112. [6] Koskela HL, Eldfors S, Ellonen P, et al. Somatic STAT3 mutations in large granular lymphocytic leukemia[J]. N Engl J Med, 2012, 366(20): 1905-1913. [7] Kennedy JA, Medeiros JJF, Dobson SM, et al. Distinct patterns of clonal evolution in patients with concurrent myelo- and lymphoproliferative neoplasms[J]. Blood, 2018, 132(20): 2201-2205. [8] Dong QZ, Xiu Y, Bossler A, et al. CLL dedifferentiation to clonally related myeloid cells[J]. Blood Adv, 2020, 4(24): 6169-6174. [9] Porpaczy E, Tripolt S, Hoelbl-Kovacic A, et al. Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy[J]. Blood, 2018, 132(7): 694-706. [10] Rumi E, Baratè C, Benevolo G, et al. Myeloproliferative and lymphoproliferative disorders: State of the art[J]. Hematol Oncol, 2020, 38(2): 121-128. [11] Mouchel PL, Syrykh C, Laurent C, et al. First case of classical Hodgkin-like EBV-positive lymphoproliferative disorder under ruxolitinib therapy[J]. Am J Hemato, 2021, 96(6): 755-756. [12] Pemmaraju N, Kantarjian H, Nastoupil L, et al. Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy[J]. Blood, 2019, 133(21): 2348-2351. [13] Wang J C, Kundra A, Andrei M, et al. Myeloid-derived suppressor cells in patients with myeloproliferative neoplasm[J]. Leuk Res, 2016, 43: 39-43. doi: 10.1016/j.leukres.2016.02.004. [14] Dumitriu B, Ito S, Feng X, et al. Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study[J]. Lancet Haematol, 2016, 3(1): e22-e29. [15] Tefferi A. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management[J]. Am J Hematol, 2021, 96(1): 145-162. |
| [1] | 周兰兰,潘学谊,郭煜. 48例急性混合细胞表型白血病患者的临床特征及预后[J]. 山东大学学报（医学版）, 2017, 55(2): 79-83. |
| [2] | 杨娟, 邱宗建, 宋强. 辛伐他汀对急性髓系白血病NB4细胞株DNA甲基转移酶的影响[J]. 山东大学学报（医学版）, 2015, 53(6): 28-32. |
| [3] | 邱宗建，杨娟，宋强 . 地西他滨对同步化的G0/G1期MDS-L细胞系线粒体功能的影响[J]. 山东大学学报（医学版）, 2014, 52(5): 5-9. |
| [4] | 翟珊珊1，丁卜同2，李海霞3，陈昀1，常亚丽1，桑坦1，郭农建1. 伴13号染色体缺失的多发性骨髓瘤患者CD138+细胞差异表达miRNAs的筛选[J]. 山东大学学报(医学版), 2013, 51(5): 80-84. |
| [5] | 孙元欣1, 秦雪梅1, 刘希民2, 王立志2, 刘传方1, 刘璐1. 异基因造血干细胞移植后aGVHD与调节性T细胞、IL-35的相关性[J]. 山东大学学报(医学版), 2013, 51(3): 89-94. |
| [6] | 徐佳, 宋强 . 骨髓增生异常综合征患者RASSF1A基因启动子区甲基化及基因表达的缺失[J]. 山东大学学报(医学版), 2013, 51(2): 65-69. |
| [7] | 尹冬梅1，许洪志1，张婧瑶1，隋潇徽1，崔彬2，马春燕2，甄长青1. AA、MDS和AML患者CD4+T细胞亚群的变化及其临床意义[J]. 山东大学学报(医学版), 2012, 50(3): 66-70. |
| [8] | 桑坦1，丁卜同2，常亚丽1，陈昀1，李志红2，汪运山2，韩淑毅2，童书青2，郭农建1. 成人急性淋巴细胞白血病ETV6基因重排分析及其临床意义[J]. 山东大学学报(医学版), 2012, 50(3): 79-82. |
| [9] | 王睿婕1，许洪志1，黄敏3，马春燕2，隋潇徽1，刘新1，张炳昌3，李元堂3. MDS、AA和AL患者骨髓细胞周期及增殖特征的研究[J]. 山东大学学报(医学版), 2011, 49(2): 97-101. |
| [10] | 周丽云，宋强，李丽珍，赵川莉，王鲁群. 骨髓异常增生综合征患者FLT3基因的表达及意义[J]. 山东大学学报(医学版), 2010, 48(4): 91-. |
| [11] | 孙佩1,2，高庆贞2，任万军2，张瑞斌2，王小平2，刘子栋2. 异基因骨髓细胞在大鼠体内嵌合分布特性的研究[J]. 山东大学学报(医学版), 2010, 48(1): 38-. |
| [12] | . 骨髓增生异常综合征患者骨髓p15基因的表达缺失与启动子甲基化[J]. 山东大学学报(医学版), 2009, 47(10): 106-109. |
| [13] | 赵广玲1 ，许洪志1 ，黄敏1 ,李元堂2 ，武焕玲2 ，李建峰3 ，马春燕3 . 骨髓增生异常综合征和再生障碍性贫血患者 骨髓原始细胞免疫表型分析[J]. 山东大学学报(医学版), 2009, 47(02): 53-57. |
| [14] | 靳 红,丛雅琴,胡晓静,姜育杰 . 骨髓增生异常综合征患者线粒体DNA D-loop区突变研究[J]. 山东大学学报(医学版), 2008, 46(5): 453-456. |
| [15] | 王艳,张宇卉,胡耐博,滕广帅,周圆,白洁. 基于单细胞测序分析急性髓系白血病患者骨髓免疫微环境的特点[J]. 山东大学学报 (医学版), 2021, 59(10): 32-40. |
|
||
